[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2021 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 135.27%
YoY- 156.28%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 1,723,276 962,174 4,815,015 4,103,297 1,970,622 793,499 2,725,071 -26.38%
PBT 41,960 37,439 277,075 151,987 53,768 31,524 35,793 11.21%
Tax -12,190 -8,583 -104,870 -64,947 -17,052 -8,696 -9,524 17.93%
NP 29,770 28,856 172,205 87,040 36,716 22,828 26,269 8.72%
-
NP to SH 28,456 27,734 172,150 86,675 36,840 23,136 27,489 2.33%
-
Tax Rate 29.05% 22.93% 37.85% 42.73% 31.71% 27.59% 26.61% -
Total Cost 1,693,506 933,318 4,642,810 4,016,257 1,933,906 770,671 2,698,802 -26.76%
-
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 17,029 10,479 121,768 56,292 30,100 10,468 28,761 -29.55%
Div Payout % 59.84% 37.79% 70.73% 64.95% 81.71% 45.25% 104.63% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
NOSH 1,309,126 1,309,126 1,309,336 1,309,126 261,991 261,705 261,705 193.35%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 1.73% 3.00% 3.58% 2.12% 1.86% 2.88% 0.96% -
ROE 7.01% 6.70% 38.22% 22.14% 10.31% 6.50% 8.15% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 131.55 73.45 367.74 313.44 150.58 303.20 1,042.20 -74.93%
EPS 2.17 2.12 13.15 6.62 2.82 8.84 10.51 -65.16%
DPS 1.30 0.80 9.30 4.30 2.30 4.00 11.00 -76.01%
NAPS 0.31 0.316 0.344 0.299 0.273 1.36 1.29 -61.44%
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 119.57 66.76 334.09 284.71 136.73 55.06 189.08 -26.38%
EPS 1.97 1.92 11.94 6.01 2.56 1.61 1.91 2.08%
DPS 1.18 0.73 8.45 3.91 2.09 0.73 2.00 -29.72%
NAPS 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 0.234 13.23%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 0.595 0.755 0.74 0.835 5.29 3.26 5.00 -
P/RPS 0.45 1.03 0.20 0.27 3.51 1.08 0.48 -4.22%
P/EPS 27.39 35.66 5.63 12.61 187.92 36.88 47.56 -30.84%
EY 3.65 2.80 17.77 7.93 0.53 2.71 2.10 44.70%
DY 2.18 1.06 12.57 5.15 0.43 1.23 2.20 -0.60%
P/NAPS 1.92 2.39 2.15 2.79 19.38 2.40 3.88 -37.51%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 -
Price 0.595 0.72 0.76 0.845 0.925 4.03 3.49 -
P/RPS 0.45 0.98 0.21 0.27 0.61 1.33 0.33 23.03%
P/EPS 27.39 34.01 5.78 12.76 32.86 45.59 33.20 -12.06%
EY 3.65 2.94 17.30 7.84 3.04 2.19 3.01 13.75%
DY 2.18 1.11 12.24 5.09 2.49 0.99 3.15 -21.81%
P/NAPS 1.92 2.28 2.21 2.83 3.39 2.96 2.71 -20.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment